936623-90-4 LCZ696

LCZ696

英文名称:LCZ696
CAS:

936623-90-4

分子式:C49H59N6Na3O8
精选商品
  • 化合物简介
  • 基本信息
  • 编号系统
  • MSDS

LCZ696简介

Valsartan/sacubitril (brand name Entresto) is a combination drug for use in heart failure developed by Novartis. It consists of the angiotensin receptor blocker valsartan and the neprilysin inhibitor sacubitril, in a 1:1 mixture by molecule count. It may be used instead of an ACE inhibitor or an angiotension receptor blocker in people with heart failure with reduced ejection fraction.
Side effects include angioedema, kidney problems, and low blood pressure. The combination is sometimes described as an "angiotensin receptor-neprilysin inhibitor" (ARNi).
It was approved under the FDA's priority review process on July 7, 2015. It is also approved in Europe. The wholesale cost for a year of Entresto is $4,560 per person as of 2015. Similar class generic drugs without sacubitril, such as valsartan alone, cost approximately $48 a year.

LCZ696基本信息

中文名称 LCZ696 英文名称 LCZ696
中文别名

查看更多中文别名
英文别名

Entresto; L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, compd. with α-ethyl (αR,γS)-γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl[1,1'-biphenyl]-4-pentanoate, sodium salt, hydrate (2:2:6:5); trisodium [3-((1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3-methyl-2-(pentanoyl{2”-(tetrazol-5-ylate)biphenyl-4-ylmethyl}amino)butyrate] hemipentahydrate; trisodium 3-((1S,3R)-1-(biphenyl-4-ylmethyl)-3-(ethoxycarbonyl)butylcarbamoyl)propionate (S)-3-methyl-2-(pentanoyl-(2-(tetrazol-1-at-5-yl)biphenyl-4'-ylmethyl)amino)butyrate hemipentahydrate;

查看更多英文别名
CAS号 936623-90-4 分子式 C49H59N6Na3O8
分子量 928.99700 精确质量 928.40900
PSA 207.53000 LOGP 5.98340

LCZ696编号系统

UNII WB8FT61183
SDS 1.0 中文 展开
SDS 1.0 英文 展开
LCZ696
CAS号:936623-90-4 分子式:C49H59N6Na3O8 分子量:928.99700

化工圈APP

二维码

微信公众号

二维码

购物车

不要让您的购物车空着哦,买试剂买原料
如果您已添加过宝贝,那就赶紧登录查看吧

投诉建议

  • 咨询类别
  • 问题描述
  • 联系人电话
  • 联系人